GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Cyclically Adjusted Price-to-FCF

Hans Biomed (XKRX:042520) Cyclically Adjusted Price-to-FCF : (As of May. 21, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hans Biomed Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Hans Biomed's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Cyclically Adjusted Price-to-FCF Chart

Hans Biomed Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hans Biomed Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hans Biomed's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Hans Biomed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hans Biomed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hans Biomed's Cyclically Adjusted Price-to-FCF falls into.


;
;

Hans Biomed Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Hans Biomed's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Hans Biomed's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-135.654/121.1352*121.1352
=-135.654

Current CPI (Dec. 2024) = 121.1352.

Hans Biomed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -133.244 99.721 -161.857
201506 -15.514 100.051 -18.783
201509 -171.414 100.111 -207.413
201512 -62.456 100.220 -75.490
201603 -218.509 100.561 -263.215
201606 -294.960 100.791 -354.497
201609 -489.057 101.461 -583.888
201612 -642.075 101.561 -765.822
201703 -41.369 102.851 -48.724
201706 59.299 102.611 70.004
201709 -259.346 103.491 -303.563
201712 52.269 102.991 61.477
201803 209.267 104.101 243.510
201806 116.945 104.130 136.043
201809 -125.361 105.651 -143.735
201812 68.274 104.351 79.256
201903 -408.165 104.491 -473.181
201906 -599.927 104.881 -692.903
201909 54.539 105.200 62.800
201912 -18.013 105.121 -20.757
202003 -170.194 105.354 -195.687
202006 -252.759 105.112 -291.290
202009 89.415 106.198 101.992
202012 -370.643 105.765 -424.505
202103 -587.993 107.357 -663.455
202106 -398.780 107.579 -449.033
202109 -624.400 108.759 -695.452
202112 -263.339 109.676 -290.852
202203 -15.434 111.848 -16.716
202206 -165.652 114.072 -175.909
202209 -208.150 114.715 -219.799
202212 -67.960 115.179 -71.474
202303 -207.047 116.507 -215.271
202306 -156.733 117.182 -162.020
202309 -115.402 118.964 -117.509
202312 37.490 118.837 38.215
202403 44.556 120.123 44.931
202406 -47.781 120.007 -48.230
202409 -110.627 120.861 -110.878
202412 -135.654 121.135 -135.654

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hans Biomed  (XKRX:042520) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Hans Biomed Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hans Biomed Business Description

Traded in Other Exchanges
N/A
Address
No.7, Jeong-i-ro 8-gil, Songpa-gu, Seoul, KOR
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.

Hans Biomed Headlines

No Headlines